L
L. De Bolle
Researcher at Ghent University
Publications - 5
Citations - 448
L. De Bolle is an academic researcher from Ghent University. The author has contributed to research in topics: Randomized controlled trial & Pharmacist. The author has an hindex of 4, co-authored 5 publications receiving 393 citations.
Papers
More filters
Journal ArticleDOI
Effectiveness of pharmacist intervention for asthma control improvement
Els Mehuys,L. Van Bortel,L. De Bolle,I. Van Tongelen,Lieven Annemans,J.P. Remon,Guy Brusselle +6 more
TL;DR: In conclusion, pragmatic community pharmacy-based programmes can significantly improve therapeutic outcomes in adult asthma patients.
Journal ArticleDOI
Effectiveness of a community pharmacist intervention in diabetes care : a randomized controlled trial.
Els Mehuys,L. Van Bortel,L. De Bolle,I. Van Tongelen,Lieven Annemans,Jean Paul Remon,Mimi Giri +6 more
TL;DR: There is little evidence from well‐designed randomized controlled trials of the impact of community pharmacist intervention on the clinical management of patients with type 2 diabetes, and how sustainable any observed effects on glycaemic control are, over time.
Journal ArticleDOI
Self-medication of regular headache: a community pharmacy-based survey.
Els Mehuys,Koen Paemeleire,T. Van Hees,Thierry Christiaens,L. Van Bortel,I. Van Tongelen,L. De Bolle,Jean Paul Remon,Koen Boussery +8 more
Abstract: Background: This observational community pharmacy-based study aimed to investigate headache characteristics and medication use of persons with regular headache presenting for self-medication.
Methods: Participants (n = 1205) completed (i) a questionnaire to assess current headache medication and previous physician diagnosis, (ii) the ID Migraine Screener (ID-M), and (iii) the Migraine Disability Assessment questionnaire.
Results: Forty-four percentage of the study population (n = 528) did not have a physician diagnosis of their headache, and 225 of them (225/528, 42.6%) were found to be ID-M positive. The most commonly used acute headache drugs were paracetamol (used by 62% of the study population), NSAIDs (39%), and combination analgesics (36%). Only 12% of patients physician-diagnosed with migraine used prophylactic migraine medication, and 25% used triptans. About 24% of our sample (n = 292) chronically overused acute medication, which was combination analgesic overuse (n = 166), simple analgesic overuse (n = 130), triptan overuse (n = 19), ergot overuse (n = 6), and opioid overuse (n = 5). Only 14.5% was ever advised to limit intake frequency of acute headache treatments.
Conclusions: This study identified underdiagnosis of migraine, low use of migraine prophylaxis and triptans, and high prevalence of medication overuse amongst subjects seeking self-medication for regular headache. Community pharmacists have a strategic position in education and referral of these self-medicating headache patients.
Journal ArticleDOI
Medication management among home-dwelling older patients with chronic diseases: Possible roles for community pharmacists
Els Mehuys,L. Dupond,Mirko Petrovic,Thierry Christiaens,L. Van Bortel,Els Adriaens,L. De Bolle,I. Van Tongelen,Jean Paul Remon,Koen Boussery +9 more
TL;DR: Some aspects of medication management by home-dwelling older adults that could be improved by pharmaceutical care sendces are identified; assistance of cognitively impaired patients, management of practical drug taking problems, DDI screening, drug adherence, and chronic benzodiazepine use.
Journal Article
Management of COPD in community pharmacy
Els Mehuys,Koen Boussery,Els Adriaens,L. Van Bortel,L. De Bolle,I. Van Tongelen,J.P. Remon,Guy Brusselle +7 more
TL;DR: This study on COPD management in primary care highlights 4 main aspects which could be improved: (i) drug adherence, (ii) inhalation technique with pMDI's, (iii) influenza vaccination in COPD patients < yr and (iv) smoking cessation.